121 related articles for article (PubMed ID: 36303403)
1. Effect of Serum C-Peptide Levels on the Development of Contrast-Induced Nephropathy in Diabetic Patients Undergoing Coronary Angiography.
Toprak K
Angiology; 2024 Feb; 75(2):139-147. PubMed ID: 36303403
[TBL] [Abstract][Full Text] [Related]
2. A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes.
Zeng JF; Chen SQ; Ye JF; Chen Y; Lei L; Liu XQ; Liu Y; Wang Y; Lin JJ; Chen JY
Clin Exp Nephrol; 2019 Jul; 23(7):969-981. PubMed ID: 31049747
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of post-procedural hyponatremia on contrast-induced nephropathy in patients who underwent coronary angiography or percutaneous coronary intervention.
Gucun M; Kahyaoglu M; Celik M; Guner A; Akyuz O; Yilmaz Y
Acta Cardiol; 2022 May; 77(3):215-221. PubMed ID: 34032177
[TBL] [Abstract][Full Text] [Related]
4. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
[TBL] [Abstract][Full Text] [Related]
5. Serum osmolarity as a potential predictor for contrast-induced nephropathy following elective coronary angiography.
Kanbay M; Siriopol D; Ozdogan E; Afsar B; Ertuglu LA; Grigore M; Sag AA; Kuwabara M; Lanaspa MA; Ortiz A; Johnson RJ; Covic A
Int Urol Nephrol; 2020 Mar; 52(3):541-547. PubMed ID: 32008199
[TBL] [Abstract][Full Text] [Related]
6. Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention.
Barbieri L; Verdoia M; Schaffer A; Cassetti E; Di Giovine G; Marino P; Suryapranata H; De Luca G
Diabetes Res Clin Pract; 2014 Dec; 106(3):458-64. PubMed ID: 25458324
[TBL] [Abstract][Full Text] [Related]
7. Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
Kurtul A; Yarlioglues M; Murat SN; Demircelik MB; Acikgoz SK; Ergun G; Duran M; Cetin M; Ornek E
Angiology; 2015 May; 66(5):433-40. PubMed ID: 24834929
[TBL] [Abstract][Full Text] [Related]
8. Drug Effects and Clinical Investigations for Contrast-Induced Nephropathy After Coronary Angiography or Percutaneous Coronary Intervention in Patients With Diabetes.
Zhang MM; Lv QZ; Li XY
Am J Ther; 2017; 24(4):e423-e430. PubMed ID: 26308327
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Fasting Blood Glucose Levels and the Risk of Contrast-Induced Nephropathy in Patients With Diabetes and Pre-diabetes Undergoing Coronary Arteriography or Percutaneous Coronary Intervention: A Cross-Sectional Study.
Zhang P; Fu H; Liu J; Liu X; Yang S; Guo Z; Fu N
Angiology; 2022 Aug; 73(7):660-667. PubMed ID: 35084237
[TBL] [Abstract][Full Text] [Related]
10. Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention.
Zhang H; Fu H; Fu X; Zhang J; Zhang P; Yang S; Zeng Z; Fu N; Guo Z
BMC Nephrol; 2021 Jun; 22(1):206. PubMed ID: 34078303
[TBL] [Abstract][Full Text] [Related]
11. Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease.
Demir OM; Lombardo F; Poletti E; Laricchia A; Beneduce A; Maccagni D; Slavich M; Giannini F; Carlino M; Margonato A; Cappelletti A; Colombo A; Azzalini L
Am J Cardiol; 2018 Dec; 122(11):1837-1842. PubMed ID: 30292337
[TBL] [Abstract][Full Text] [Related]
12. Association between N-terminal pro-brain natriuretic peptide levels and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
Kurtul A; Duran M; Yarlioglues M; Murat SN; Demircelik MB; Ergun G; Acikgoz SK; Sensoy B; Cetin M; Ornek E
Clin Cardiol; 2014 Aug; 37(8):485-92. PubMed ID: 24805995
[TBL] [Abstract][Full Text] [Related]
13. CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
Wang Y; Zhao HW; Zhang XJ; Chen BJ; Yu GN; Hou AJ; Luan B
BMC Cardiovasc Disord; 2019 Mar; 19(1):74. PubMed ID: 30922230
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of hemoglobin to creatinine ratio for contrast-induced nephropathy in percutaneous coronary interventions.
Çamci S; Kinik M; Ari S; Ari H; Melek M; Bozat T
Clin Chem Lab Med; 2022 Aug; 60(9):1455-1462. PubMed ID: 35727209
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of contrast-induced nephropathy after percutaneous coronary intervention: a retrospective analysis.
Wang J; Zhang C; Liu Z; Bai Y
J Int Med Res; 2021 Apr; 49(4):3000605211005972. PubMed ID: 33878914
[TBL] [Abstract][Full Text] [Related]
16. Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
Oksuz F; Yarlioglues M; Cay S; Celik IE; Mendi MA; Kurtul A; Cankurt T; Kuyumcu S; Canpolat U; Turak O
Am J Cardiol; 2015 Sep; 116(5):711-6. PubMed ID: 26116992
[TBL] [Abstract][Full Text] [Related]
17. Association of contrast-induced nephropathy with bare metal stent restenosis in STEMI patients treated with primary PCI.
Güngör B; Karataş MB; İpek G; Özcan KS; Çanga Y; Onuk T; Keskin M; Hayıroğlu Mİ; Karadeniz FÖ; Sungur A; Öztürk R; Bolca O
Ren Fail; 2016 Sep; 38(8):1167-73. PubMed ID: 27436614
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous coronary intervention causes increase of serum cystatin C concentration even in the patients with a low risk of contrast-induced nephropathy.
Tanaga K; Tarao K; Nakamura Y; Inoue T; Jo K; Ishikawa T; Miyazaki A
Cardiovasc Interv Ther; 2012 Sep; 27(3):168-73. PubMed ID: 22692693
[TBL] [Abstract][Full Text] [Related]
19. Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure.
Cho JY; Jeong MH; Hwan Park S; Kim IS; Park KH; Sim DS; Yoon NS; Yoon HJ; Park HW; Hong YJ; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
J Cardiol; 2010 Nov; 56(3):300-6. PubMed ID: 20708903
[TBL] [Abstract][Full Text] [Related]
20. [Clinical impact of nephropathy induced by contrast medium in patients with acute myocardial infarction undergoing emergent coronary angiography].
Jujo K; Yamaguchi J; Obayashi K; Suzuki K; Sekiguchi H; Nagashima M; Tsurumi Y; Kasanuki H
J Cardiol; 2006 Jul; 48(1):9-16. PubMed ID: 16886495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
